ATXI - Avenue Therapeutics GAAP EPS of $15.40 beats by $24.40
2024-05-16 01:35:18 ET
More on Avenue Therapeutics
- Avenue Therapeutics drops 9% on 1-for-75 reverse split
- Avenue Therapeutics granted extension for Nasdaq compliance
- Seeking Alpha’s Quant Rating on Avenue Therapeutics
- Historical earnings data for Avenue Therapeutics
- Financial information for Avenue Therapeutics